实体器官移植患者头颈显微血管重建结局:单中心经验与Meta分析
该系统综述与汇总比例Meta分析及单中心回顾性数据库回顾比较了移植与非移植患者头颈游离皮瓣重建的结局。移植患者皮瓣成功率与非移植患者相当,但受区/供区并发症更高,总体死亡率显著更高。移植患者头颈鳞癌预后较差,可能受益于专门的治疗指南。
要点
- 移植患者头颈游离皮瓣成功率约97%,与非移植患者相当。
- 移植患者受区/供区裂开、皮瓣丢失和再手术率显著更高。
- 移植患者总体死亡率显著更高(64% vs 23%),但两年死亡率无差异。
核心结论
- 移植患者游离皮瓣存活率与非移植患者相当,但术后并发症率更高且总体死亡率更高。
研究设计与样本
- 系统综述与汇总比例Meta分析,纳入4项符合条件的研究;单中心回顾性数据库回顾纳入14例移植患者。
- 系统综述中肾移植和股前外侧皮瓣最常见,泼尼松为主要免疫抑制剂;本中心他克莫司最常见。
主要发现
- 系统综述汇总皮瓣成功率为97%,受区和供区并发症率分别为21%和16%。
- 本中心移植患者受区/供区裂开、皮瓣丢失和再手术显著更高;感染、涎漏、硬件外露或血肿率相似。
- 移植患者总体死亡率显著更高(64% vs 23%;p < 0.001),但Kaplan-Meier分析两年死亡率无差异。
关键数值与推荐
- 汇总皮瓣成功率97%,受区并发症率21%,供区并发症率16%。
- 移植患者总体死亡率64% vs 非移植患者23%(p < 0.001)。
临床怎么用
- 移植患者头颈游离皮瓣重建应预期更高的受区/供区并发症和再手术风险。
- 鉴于预后较差,移植患者头颈鳞癌可能需要专门的治疗指南。
局限性
- 系统综述仅纳入4项符合条件的研究,证据有限。
- 单中心回顾性数据库样本量小(14例移植患者),可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Solid organ transplant recipients are at increased risk of developing head and neck squamous cell carcinoma (HNSCC). These patients often require free flap reconstruction; however, data on outcomes in this immunosuppressed population remain limited and formal management guidelines are lacking. METHODS: We conducted a systematic review and pooled proportions meta-analysis, and a retrospective institutional database review, to compare outcomes of head and neck free flap reconstruction in transplant versus non-transplant patients. Cancer-related mortality and time from surgery to death were also assessed. RESULTS: The systematic review yielded four eligible studies. Kidney transplantation and anterolateral thigh flaps were the most common. Prednisone was the predominant immunosuppressant. The pooled flap success rate was 97%, with recipient and donor site complication rates of 21% and 16%, respectively. Our database had 14 transplant patients who underwent head and neck reconstruction for oral SCC (n = 12) or osteoradionecrosis (n = 2). Tacrolimus was the most common immunosuppressant. Recipient/donor site dehiscence, skin graft loss, and reoperation were significantly higher in transplant patients. Rates of infection, salivary leak, hardware exposure, or hematoma were similar. Overall mortality was significantly higher in transplant patients (64% vs. 23%; p < 0.001), although the 2-year mortality did not differ on Kaplan-Meier analysis. CONCLUSION: Although free flap survival in transplant patients is comparable to non-transplant patients, postoperative complication rates are higher. Given their distinct risk profile and poorer prognosis, transplant patients with HNSCC may benefit from dedicated treatment guidelines.
引用
- Orbay H, Bengur FB, Dominguez E, et al. Outcomes of microvascular head and neck reconstruction in solid organ transplant patients: A single institution experience and meta-analysis. J Plast Reconstr Aesthet Surg. 2026. PMID: 41812576. doi:10.1016/j.bjps.2026.02.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。